Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Search

Astellas Pharma Inc. GLOBAL
  • About
    • Philosophy
      • Charter of Corporate Conduct
    • President and CEO’s Message
    • Vision & Strategy
    • Corporate Governance
      • Group Code of Conduct
    • Risk Management
    • Corporate Information
      • Subsidiaries & Locations
    • History
    • Board of Directors
    • Top Management
    • Main Products
    • Policies & Position Statements
    • Ethics & Compliance
    • Medical Care & Pharmaceutical Information
    Recommended
    Strategic Plan 2018
    Read More
  • Science
    • Focus Area Approach
    • Astellas Biomedical Innovation Hub
    • Rx+®
    • Data, Informatics and Analytics
    • Major Pipeline
    • Clinical Trials
    • Investigator Sponsored Research
    Recommended
    Focus Area Approach

    The Focus Area, where we put our efforts, consists of combinations of three components: 1) biology, 2) modality/technology, 3) diseases.

    Read More
  • Partnering
    • Areas of Interest
    • Why Partner with Astellas
    • Primary Focus
      • Blindness & Regeneration
      • Mitochondria Biology
      • Genetic Regulation
      • Immuno-Oncology
    • Biology, Modality/Technology of Interest
      • Innate Immunity (Innate Lymphoid Cells)
      • Autophagy
      • Protein Knockdown
    • Primary Focus Candidates
    • Cell Therapy
    • Rx+® - New Healthcare Solutions Beyond Medicine
      • Chronic Disease Progression Prevention
      • Motor Function Support/Replacement
      • Digital × Neuroscience
      • Patient w/o Effective Medicines
      • Patient Outcome Maximization via Precise Surgery/Diagnosis
      • Sensory Function Support/Replacement
    • Partnering Teams
    • Get in Touch
    • For Academics
    Recommended
    Areas of Interest

    Astellas monitors Focus Areas from biology perspectives, modality/technology, and disease to identify promising areas for investment. 

    Read More
  • Responsibility
    • Our Commitment
      • United Global Compact
    • CSR-Based Management
      • Materiality
      • SDGs
      • ISO26000
      • 30% Club
    • Stakeholder Communications
      • Communication with the World Anti-Doping Agency (WADA)
    • CSR Activities in Five Fields
      • Society
        • Advancement of Medical Sciences
        • Changing Tomorrow Day
        • Astellas Foundation
      • Environment
        • Definition of terms
        • EHS Management
          • Status of obtaining ISO 14001 Certification
          • Astellas Environment, Health & Safety Guidelines
        • Environment Initiatives
        • Climate Change Mitigation Measures
        • Breakdown of Energy Consumption
        • Sustainable Biodiversity Initiatives
          • Biodiversity and Astellas An Enlarged Version
          • The Biodiversity Burden Index and Revenue
        • Initiatives for Resource Recycling
        • Initiatives for Preventing Pollution
          • Further information on PRTR system
        • Environmental Impact of Products and Countermeasures
        • Environmental Accounting
          • Environment-related Investments and Expenses
        • Reporting coverage, methods, etc.
        • EHS Report
        • Independent Assurance Report
      • EMPLOYEES
        • HR Vision
        • Providing Opportunities for Employees to Succeed Globally
        • Diversity Management
        • Promoting Health Management
        • Occupational Health & Safety
        • Respect for Human Rights
        • Data
      • Ethics & Compliance
    • Business Activities
      • Responsible Business Activities
        • ISO certification status of Astellas plants
      • With our Business Partners
        • Basic policy for procurement activities involving suppliers
      • Modern Slavery Act 2015
      • Individual HCP Funding Decision
    • Access to Health
      • Research Activities on Tuberculosis and Malaria
      • Research Activities on NTDs
      • Access Accelerated
      • Action on Fistula
      • Development of Pediatric Formulation for Schistosomiasis
      • GHIT Fund
    • Awards & Recognition
    Recommended
    Access Accelerated

    Astellas participates in Access Accelerated. Access Accelerated is a first-of-its-kind, multi-stakeholder collaboration focused on improving...

    Read More
  • News
    • News
    • Stories
    Recommended
    Stories

    Stories about how Astellas members work to create innovation, as well as achieve business and sustainability strategic goals.

    Read More
  • Investors
    • Strategic Plan 2018
    • Financial Information
      • Financial Highlights
      • Financial Data (Annual Data)
      • Financial Data (Quarterly Data)
      • Sales of Major Products
      • Revenue by Region
    • Annual Report
    • IR Library
      • Business Results
      • Overview of R&D Pipeline
      • IR Meetings
      • Consolidated Financial Statements and Footnotes
      • Corporate Governance Materials
    • IR Calendar
    • Stock & Rating Information
      • Shareholders Meeting
      • Shareholder Return
      • Current Share Status
      • Chart
      • Issuer Rating
    • Analyst Coverage
    • Cautionary Statement
    Recommended
    Financial Information

    Review our consolidated business results, forecasts and financial data, etc.

    Read More

Common header menu

  • IMPORTANT NOTICE
  • WORLDWIDE
  1. Home
  2. Investors
  3. IR Library
  4. Corporate Governance Materials

Corporate Governance Materials

Important Notice

This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site.

Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

I Agree
logo
Thank you for visiting the Astellas Pharma Inc. Website.
You will enter external sites beyond here.
(This link opens in a new window)
Cancel Click here to leave this site.
  • Facebook
  • Linkedin
  • Twitter

Investors

  • Strategic Plan 2018
  • Financial Information
    • Financial Highlights
    • Financial Data (Annual Data)
    • Financial Data (Quarterly Data)
    • Sales of Major Products
    • Revenue by Region
  • Annual Report
  • IR Library
    • Business Results
    • Overview of R&D Pipeline
    • IR Meetings
    • Consolidated Financial Statements and Footnotes
    • Corporate Governance Materials
  • IR Calendar
  • Stock & Rating Information
    • Shareholders Meeting
    • Shareholder Return
    • Current Share Status
    • Chart
    • Issuer Rating
  • Analyst Coverage
  • Cautionary Statement

Bottom footer menu

  • SITE MAP
  • PRIVACY POLICY
  • ACCESSIBILITY
  • TERMS OF USE
  • CONTACT US
  • DISASTER INFORMATION FOR EMPLOYEES
© Astellas Pharma Inc.